Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Advanced Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic Effect
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- NA
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
- Status
- COMPLETED
- Phase
- PHASE1
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeted Internal Radiation Therapy in Advanced HCC Patients.
- Status
- COMPLETED
- Phase
- NA
Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2